{"version":"1.0","type":"link","title":"Andamertinib in Advanced NSCLC With EGFR Exon 20 Insertions After Platinum-Based Chemotherapy or Immunotherapy: Results From the Phase 2 KANNON Study.","author_name":"Yang JJ 외","author_url":"https://prs-insight.online/author/Yang%20JJ","provider_name":"PRSinsight","provider_url":"https://prs-insight.online","thumbnail_url":"https://prs-insight.online/og/paper/96565","thumbnail_width":1200,"thumbnail_height":630}